rs20424

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The ENST00000608917.4(PACERR):​n.379G>A variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000311 in 321,634 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000031 ( 0 hom. )

Consequence

PACERR
ENST00000608917.4 non_coding_transcript_exon

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.92

Publications

7 publications found
Variant links:
Genes affected
PACERR (HGNC:50552): (PTGS2 antisense NFKB1 complex-mediated expression regulator RNA) This gene represents transcription of a long non-coding RNA produced in antisense to the prostaglandin-endoperoxide synthase 2 (PTGS2) gene. This transcript interacts with NF-kB transcriptional regulators to promote expression of PTGS2. [provided by RefSeq, Feb 2015]
PTGS2 (HGNC:9605): (prostaglandin-endoperoxide synthase 2) Prostaglandin-endoperoxide synthase (PTGS), also known as cyclooxygenase, is the key enzyme in prostaglandin biosynthesis, and acts both as a dioxygenase and as a peroxidase. There are two isozymes of PTGS: a constitutive PTGS1 and an inducible PTGS2, which differ in their regulation of expression and tissue distribution. This gene encodes the inducible isozyme. It is regulated by specific stimulatory events, suggesting that it is responsible for the prostanoid biosynthesis involved in inflammation and mitogenesis. [provided by RefSeq, Feb 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.58).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PTGS2NM_000963.4 linkc.-196C>T upstream_gene_variant ENST00000367468.10 NP_000954.1
PACERRNR_125801.1 linkn.-168G>A upstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PTGS2ENST00000367468.10 linkc.-196C>T upstream_gene_variant 1 NM_000963.4 ENSP00000356438.5

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000311
AC:
1
AN:
321634
Hom.:
0
Cov.:
4
AF XY:
0.00000591
AC XY:
1
AN XY:
169126
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
7626
American (AMR)
AF:
0.00
AC:
0
AN:
10214
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
10534
East Asian (EAS)
AF:
0.00
AC:
0
AN:
23360
South Asian (SAS)
AF:
0.00
AC:
0
AN:
25220
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
25324
Middle Eastern (MID)
AF:
0.000674
AC:
1
AN:
1484
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
198400
Other (OTH)
AF:
0.00
AC:
0
AN:
19472
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.58
CADD
Benign
17
DANN
Benign
0.85
PhyloP100
1.9
PromoterAI
-0.090
Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs20424; hg19: chr1-186649618; API